BETAPLUS PHARMA
ActiveSummary
BETAPLUS PHARMA has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €22.3m and a net result of €1.3m. Equity is growing by about 7.6% per year across the filed financial years. Its solvency ranks better than 91% of 88 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Board 5
3 not recently confirmed
Day-to-day management 2
Statutory auditor 1
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Philippe DEHASPE |
|
| Stéphan Mairlot |
|
| Francois Jamar |
|
| Beryle Zany |
|
| Vianney Battle |
|
| NV Callens Vandelanotte |
|
| Philippe Van Den Avenne |
|
| Emanuele Sensale |
|
| Stanislas Pauwels |
|
| Benoit Woessmer |
|
| Xavier Defourt |
|
| KPMG Réviseurs d'Entreprises SCRL |
|
| Dominic Rousselle |
|
| Renaud Dehareng |
|
| Emst & Young Réviseurs d'entreprises BVCVBA |
|
| Emanuel Sensale |
|
| François Labarre |
|
| Olivier LEGRAIN |
|
| Renaud Dehanreng |
|
| Gauthier SAELENS |
|
Owners and capital
Owners
2 ownersChain of control
- GLO Healthcare S.C.A.LU
- CURIUM BIDCO S.À R.L.LU
- Curium International
- BETAPLUS PHARMA
Highest known parent: GLO Healthcare S.C.A. (Luxembourg). The sources do not say who stands above it.
Owners 2
-
75%
- GLO Healthcare S.C.A.LUconsolidating parentconsolidates
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.